These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5897741)

  • 21. Subjective responses and excretion patterns of dextroamphetamine after the administration of therapeutic doses.
    Evans MA; Wimbish G; Griffis L; Martz R; Brown DJ; Rodda BE; Lemberger L; Forney RB
    J Forensic Sci; 1977 Jan; 22(1):197-201. PubMed ID: 263938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The absorption characteristics of six sustained-release theophylline preparations.
    Sommers DK; van Wyk M; Meyer EC; Snyman JR; Moncrieff J
    S Afr Med J; 1992 Jan; 81(1):20-2. PubMed ID: 1729729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative metabolism of d-amphetamine-C14 in the rat, dog and monkey.
    Ellison T; Gutzait L; Van Loon EJ
    J Pharmacol Exp Ther; 1966 Jun; 152(3):383-7. PubMed ID: 4958760
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
    Huebers H; Huebers E; Huebers U; Rummel W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R36. PubMed ID: 4276566
    [No Abstract]   [Full Text] [Related]  

  • 25. Dextroamphetamine with morphine for the treatment of postoperative pain.
    Forrest WH; Brown BW; Brown CR; Defalque R; Gold M; Gordon HE; James KE; Katz J; Mahler DL; Schroff P; Teutsch G
    N Engl J Med; 1977 Mar; 296(13):712-5. PubMed ID: 320478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of sustained-release and plain papaverine in man.
    Kanto J; Iisalo E; Manell D; Mäntylä R
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):375-7. PubMed ID: 500258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies of oral "quick-release" and "slowrelease" iron preparations in the postabsorption serum iron concentration test].
    Kilchling H
    Arzneimittelforschung; 1975 Jan; 25(1):105-10. PubMed ID: 1173763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assay procedure for spectrophotometric determination of dextroamphetamine sulfate and amobarbital formulated into timed-release capsules.
    De Fabrizio F
    J Pharm Sci; 1972 Jan; 61(1):101-2. PubMed ID: 5058621
    [No Abstract]   [Full Text] [Related]  

  • 29. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of an in vitro absorption model system for predicting sustained release of verapamil.
    Neubert R; Fahr F; Mäder C; Lücke L; Fries G; Rostock G
    Arzneimittelforschung; 1992 Sep; 42(9):1098-100. PubMed ID: 1445475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potassium absorption from sustained release tablets.
    Graffner C; Sjögren J
    Acta Pharm Suec; 1971 Mar; 8(1):13-8. PubMed ID: 5575869
    [No Abstract]   [Full Text] [Related]  

  • 32. [Propantheline in sustained-release preparations--a doubtful alternative].
    Beermann B; Rosén A
    Lakartidningen; 1972 Jun; 69():Suppl 2:26-8. PubMed ID: 4645696
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation of brain levels of drugs with behavioral effects.
    Maickel RP; Cox RH; Miller FP; Segal DS; Russell RW
    J Pharmacol Exp Ther; 1969 Feb; 165(2):216-24. PubMed ID: 5763057
    [No Abstract]   [Full Text] [Related]  

  • 34. Variations in absorption of theophylline from two sustained-release products.
    Ferrari M; Olivieri M; Barozzi E; Ramponi C
    Clin Ther; 1986; 8(6):646-54. PubMed ID: 3791362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain to serum distribution of radioactivity of injected ( 3 H)-d-amphetamine in differentially housed mice.
    DeFeudis FV; Marks JH
    Biol Psychiatry; 1973 Feb; 6(1):85-8. PubMed ID: 4710778
    [No Abstract]   [Full Text] [Related]  

  • 36. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained release preparations: estimation of plasma concentration in the one compartment open model when release is both immediate and zero order.
    Rodda BE
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):290-6. PubMed ID: 5126065
    [No Abstract]   [Full Text] [Related]  

  • 38. SYNTHETIC POLYMERS AS POTENTIAL SUSTAINED-RELEASE COATINGS.
    KLEBER JW; NASH JF; LEE CC
    J Pharm Sci; 1964 Dec; 53():1519-21. PubMed ID: 14255135
    [No Abstract]   [Full Text] [Related]  

  • 39. [Development of an oral retard preparation of verapamil and absorption study in the anesthetized dog].
    Mayer D; Raschack M; Kesselring K
    Arzneimittelforschung; 1975 Aug; 25(8):1272-5. PubMed ID: 241362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
    Kaland ME; Klein-Schwartz W
    Clin Toxicol (Phila); 2015 Jun; 53(5):477-85. PubMed ID: 25832473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.